Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F D Goebel

Showing results (221-230 of 239) with videos related to

Pageof 24
Sort By:
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 1, 1996
Epidemiology of AIDS dementia complex in Europe. AIDS in Europe Study GroupA Chiesi, S Vella, L G Dally, et al.
Lancet (London, England)|June 29, 1985
High frequency of HTLV-III antibodies among heterosexual intravenous drug abusers in the Austrian TyrolD Fuchs, H G Blecha, F Deinhardt, et al.
AIDS (London, England)|December 12, 2001
Viral load outcome of non-nucleoside reverse transcriptase inhibitor regimens for 2203 mainly antiretroviral-experienced patientsA N Phillips, C Pradier, A Lazzarin, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|March 12, 1998
Survival in 2367 zidovudine-treated patients according to use of other nucleoside analogue drugs. The EuroSIDA Study GroupA N Phillips, C Katlama, S Barton, et al.
Deutsche Medizinische Wochenschrift (1946)|March 21, 1986
[HTLV-III in persons with intravenous drug abuse. Correlation of antibodies against HTLV-III with neopterin and TH/TS]P Hengster, H G Blecha, F Deinhardt, et al.
Klinische Monatsblatter Fur Augenheilkunde|September 1, 1992
[Differences in detectability of human immunodeficiency virus type 1 in tears and blood lymphocytes]S A Geier, L Gürtler, V Klauss, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 1, 1995
Factors associated with the development of Pneumocystis carinii pneumonia in 5,025 European patients with AIDS. AIDS in Europe Study GroupJ D Lundgren, S E Barton, A Lazzarin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1993
Potent stimulation of monocytic endothelin-1 production by HIV-1 glycoprotein 120H Ehrenreich, P Rieckmann, F Sinowatz, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 14, 2000
A comparison of exposure groups in the EuroSIDA study: starting highly active antiretroviral therapy (HAART), response to HAART, and survivalA Mocroft, S Madge, A M Johnson, et al.
AIDS (London, England)|March 15, 1997
Survival of European patients with Kaposi's sarcoma as AIDS-defining condition during the first decade of AIDS. AIDS in Europe Study GroupP Hermans, J Lundgren, B Sommereijns, et al.
Pageof 24

Showing results (221-230 of 239) with videos related to

Sort By:
Pageof 24
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 1, 1996
Epidemiology of AIDS dementia complex in Europe. AIDS in Europe Study GroupA Chiesi, S Vella, L G Dally, et al.
Lancet (London, England)|June 29, 1985
High frequency of HTLV-III antibodies among heterosexual intravenous drug abusers in the Austrian TyrolD Fuchs, H G Blecha, F Deinhardt, et al.
AIDS (London, England)|December 12, 2001
Viral load outcome of non-nucleoside reverse transcriptase inhibitor regimens for 2203 mainly antiretroviral-experienced patientsA N Phillips, C Pradier, A Lazzarin, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|March 12, 1998
Survival in 2367 zidovudine-treated patients according to use of other nucleoside analogue drugs. The EuroSIDA Study GroupA N Phillips, C Katlama, S Barton, et al.
Deutsche Medizinische Wochenschrift (1946)|March 21, 1986
[HTLV-III in persons with intravenous drug abuse. Correlation of antibodies against HTLV-III with neopterin and TH/TS]P Hengster, H G Blecha, F Deinhardt, et al.
Klinische Monatsblatter Fur Augenheilkunde|September 1, 1992
[Differences in detectability of human immunodeficiency virus type 1 in tears and blood lymphocytes]S A Geier, L Gürtler, V Klauss, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 1, 1995
Factors associated with the development of Pneumocystis carinii pneumonia in 5,025 European patients with AIDS. AIDS in Europe Study GroupJ D Lundgren, S E Barton, A Lazzarin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1993
Potent stimulation of monocytic endothelin-1 production by HIV-1 glycoprotein 120H Ehrenreich, P Rieckmann, F Sinowatz, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 14, 2000
A comparison of exposure groups in the EuroSIDA study: starting highly active antiretroviral therapy (HAART), response to HAART, and survivalA Mocroft, S Madge, A M Johnson, et al.
AIDS (London, England)|March 15, 1997
Survival of European patients with Kaposi's sarcoma as AIDS-defining condition during the first decade of AIDS. AIDS in Europe Study GroupP Hermans, J Lundgren, B Sommereijns, et al.
Pageof 24